Why we should all be thrilled about the FDA starting to embrace innovation

On Feb. 19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom Syndrome. This was a startling — and good — development because it affirmed the rights of consumers to drive their own health-care decisions and procedures. […]

Por Administrador
Administrador del Sitio
Publicado el 02 de March del 2015
Last Comments

Recent Comments